The Association Between Anti-osteoporosis Medications and Lowered All Cause Mortality After Osteoporotic Fractures
This observational study aimed to assess the relationship between anti-osteoporosis medications and all-cause mortality in older adults following osteoporotic fractures. Conducted by National Cheng-Kung University Hospital, it involved a cohort of 216,155 participants and spanned a 12-year observation period.
Indication: Osteoporosis
Modality: monoclonal antibody
Target: Osteoporosis and Mortality
Sponsor: National Cheng-Kung University Hospital
Source URL: ClinicalTrials.gov
Source updated: Apr 04, 2023
Ingested: May 30, 2026
Model: trialsignal-ai-v1
Validation: validated
Matched by target_normalized: Osteoporosis and Mortality
View original source fields
Condition raw: Osteoporosis
Condition normalized: Osteoporosis
Modality raw: Osteoporosis
Modality normalized: monoclonal antibody
Target raw: Osteoporosis and Mortality
Target normalized: Osteoporosis and Mortality